AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma

Yuxuan Zhu,* Ting Yuan,* Yuan Zhang, Jianyou Shi, Lan Bai, Xingmei Duan, Rongsheng Tong, Lei Zhong Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu,...

Full description

Bibliographic Details
Main Authors: Zhu Y, Yuan T, Zhang Y, Shi J, Bai L, Duan X, Tong R, Zhong L
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:Drug Design, Development and Therapy
Subjects:
esophageal squamous cell cancer
ar-42
histone deacetylase
angiogenesis
Online Access:https://www.dovepress.com/ar-42-a-pan-hdac-inhibitor-with-antitumor-and-antiangiogenic-activitie-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/ar-42-a-pan-hdac-inhibitor-with-antitumor-and-antiangiogenic-activitie-peer-reviewed-article-DDDT

Similar Items